A 74-year-old woman is evaluated in the emergency department for a 3-day history of progressively worsening shortness of breath and increased sputum production. She has a medical history of chronic obstructive pulmonary disease (COPD), heart failure with preserved ejection fraction, and type 2 diabetes mellitus. Her current medications include lisinopril, amlodipine, metformin, and a daily tiotropium inhaler. She has a 40-pack-year smoking history. Her temperature is 37.3 °C (99.1 °F), blood pressure is 138/86 mm Hg, pulse is 92/min, and respirations are 24/min. Pulse oximetry shows an oxygen saturation of 89% on room air. The patient is sitting upright and using accessory muscles of respiration. The jugular venous pressure is 6 cm H2O. Chest auscultation reveals a prolonged expiratory phase with diffuse expiratory wheezing bilaterally. Cardiac examination shows a regular rate and rhythm with a normal S1 and S2; there are no murmurs or gallops. There is no peripheral edema. Laboratory studies show:
Leukocyte count: 9,500/mm³
Serum : 139 mEq/L
Serum : 4.1 mEq/L
Serum : 96 mEq/L
Serum : 33 mEq/L
BUN: 18 mg/dL
Creatinine: 0.9 mg/dL
Thyroid-stimulating hormone (TSH): 0.15 µU/mL (Normal: 0.4–4.0 µU/mL)
Free thyroxine (T4): 1.1 ng/dL (Normal: 0.9–2.4 ng/dL)
An arterial blood gas on room air shows:
pH: 7.35
: 60 mm Hg
: 58 mm Hg
A chest radiograph shows hyperinflated lungs and flattened diaphragms, with no focal consolidation, pleural effusion, or pulmonary vascular congestion. Which of the following is the most appropriate next step in management of this patient's current condition?
- Administer nebulized albuterol-ipratropium and systemic glucocorticoidsAnswer
- BAdminister intravenous furosemide and restrict oral fluid intake
- CAdminister intravenous piperacillin-tazobactam and vancomycin
- DAdminister a continuous intravenous infusion of sodium bicarbonate
- EInitiate therapy with oral methimazole